These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Coagulopathy as a predictor of outcome in meningococcal sepsis and the systemic inflammatory response syndrome with purpura. McManus ML; Churchwell KB Crit Care Med; 1993 May; 21(5):706-11. PubMed ID: 8482092 [TBL] [Abstract][Full Text] [Related]
45. Recurrence of neisserial meningococcemia due to deficiency of terminal complement component. Morris JT; Kelly WJ South Med J; 1992 Oct; 85(10):1030-1. PubMed ID: 1411724 [TBL] [Abstract][Full Text] [Related]
46. Heparin therapy in fulminant meningococcemia. Najjar SS; Ahmad M J Pediatr; 1969 Sep; 75(3):449-53. PubMed ID: 5804192 [No Abstract] [Full Text] [Related]
47. Severe meningococcal infection: a review of epidemiology, diagnosis, and management. Campsall PA; Laupland KB; Niven DJ Crit Care Clin; 2013 Jul; 29(3):393-409. PubMed ID: 23830646 [TBL] [Abstract][Full Text] [Related]
48. Meningococcemia complicated by myocarditis in a 16-year-old young man: a case report. Bouneb R; Mellouli M; Regaieg H; Majdoub S; Chouchène I; Boussarsar M Pan Afr Med J; 2018; 29():149. PubMed ID: 30050613 [TBL] [Abstract][Full Text] [Related]
49. Association of chronic meningococcemia with infection by meningococci with underacylated lipopolysaccharide. Brouwer MC; Spanjaard L; Prins JM; van der Ley P; van de Beek D; van der Ende A J Infect; 2011 Jun; 62(6):479-83. PubMed ID: 21459106 [TBL] [Abstract][Full Text] [Related]
50. Treatment of purpura fulminans in meningococcemia with protein C concentrate. Rivard GE; David M; Farrell C; Schwarz HP J Pediatr; 1995 Apr; 126(4):646-52. PubMed ID: 7699550 [TBL] [Abstract][Full Text] [Related]
51. Purpura fulminans from meningococcemia mimicking Stevens-Johnson syndrome in an adult patient taking etanercept. Gunawardane ND; Menon K; Guitart J; Cotliar JA Arch Dermatol; 2012 Dec; 148(12):1429-31. PubMed ID: 23247497 [No Abstract] [Full Text] [Related]
52. Life-threatening eruptions due to infectious agents. Ramos-e-Silva M; Pereira AL Clin Dermatol; 2005; 23(2):148-56. PubMed ID: 15802208 [TBL] [Abstract][Full Text] [Related]
53. Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis. Morrison DC Prog Clin Biol Res; 1998; 397():199-207. PubMed ID: 9575560 [TBL] [Abstract][Full Text] [Related]
54. Meningococcemia and intravascular clotting: the use of heparin in management. Holland P; Bobo MF; Shackelford E J Ky Med Assoc; 1968 Sep; 66(9):807-10. PubMed ID: 5681136 [No Abstract] [Full Text] [Related]
55. Meningococcal pneumonia: characterization and review of cases seen over the past 25 years. Winstead JM; McKinsey DS; Tasker S; De Groote MA; Baddour LM Clin Infect Dis; 2000 Jan; 30(1):87-94. PubMed ID: 10619738 [TBL] [Abstract][Full Text] [Related]